Clinical Trials Browser

Active not recruiting × Clear-cell metastatic renal cell carcinoma × Nivolumab × Clear all

NCT05122546 2026-03-05

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Phase 1 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell